Cytokine Release Syndrome 0.5 Contact Hours

Overview

Review of Cytokine Release Syndrome
Presented By: Amy Goodman, PA-C

Learning Objectives

The learner will be able to:

  • Define and be able to clinically recognize cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (iCANS)
  • Understand the role of tocilizumab in CRS

Additional Information

AttachmentSize
PDF icon AIS.pdf40.04 KB
Course summary
Available credit: 
  • 0.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
Course opens: 
08/08/2024
Course expires: 
08/08/2025
Part of: 
Oncology Nurse Education

Venue

Pittsburgh, PA
United States

Faculty

  • Amy Goodman, PA-C

Accreditation

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Available Credit

  • 0.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Register/Take course

Please login or register to take this course.